These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20477103)

  • 21. Immune mechanisms of lung allograft rejection.
    Snyder LD; Palmer SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):534-43. PubMed ID: 17072801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor pathways and innate responses to allografts.
    Walker WE; Goldstein DR
    Curr Opin Organ Transplant; 2007 Feb; 12(1):5-9. PubMed ID: 27792082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of donor and recipient age on allograft tolerance.
    Martins PN
    Exp Clin Transplant; 2009 Jun; 7(2):67-77. PubMed ID: 19715510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of transplantation tolerance-the potential of regulatory T cells.
    Akl A; Luo S; Wood KJ
    Transpl Immunol; 2005 Aug; 14(3-4):225-30. PubMed ID: 15982567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation 1994: the year in review.
    Browne BJ; Kahan BD
    Clin Transpl; 1994; ():317-40. PubMed ID: 7547552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation.
    Spirig R; Gajanayake T; Korsgren O; Nilsson B; Rieben R
    Mol Immunol; 2008 Oct; 45(16):4084-94. PubMed ID: 18722664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of toll-like receptors in viral infections: HIV-1 as a model].
    Hernández JC; Montoya CJ; Urcuqui-Inchima S
    Biomedica; 2007 Jun; 27(2):280-93. PubMed ID: 17713639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors and graft rejection.
    Liu G; Wu Y; Gong S; Zhao Y
    Transpl Immunol; 2006 Jun; 16(1):25-31. PubMed ID: 16701173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.
    Bowie AG
    Clin Exp Immunol; 2007 Feb; 147(2):217-26. PubMed ID: 17223961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
    Palmer SM; Burch LH; Mir S; Smith SR; Kuo PC; Herczyk WF; Reinsmoen NL; Schwartz DA
    Clin Transplant; 2006; 20(1):30-6. PubMed ID: 16556150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of pediatric heart transplantation: a clinical update.
    Webber SA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():158-84. PubMed ID: 11460982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
    Wadia PP; Tambur AR
    Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immunity and resistance to tolerogenesis in allotransplantation.
    Benichou G; Tonsho M; Tocco G; Nadazdin O; Madsen JC
    Front Immunol; 2012; 3():73. PubMed ID: 22566954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in transplantation: Conclusion].
    Lebranchu Y
    Bull Acad Natl Med; 2022 Apr; 206(4):551-553. PubMed ID: 35185154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterile inflammation in thoracic transplantation.
    Frye CC; Bery AI; Kreisel D; Kulkarni HS
    Cell Mol Life Sci; 2021 Jan; 78(2):581-601. PubMed ID: 32803398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Toll-like receptors in transplantation tolerance.
    Shen H; Goldstein DR
    Expert Rev Clin Immunol; 2007 Mar; 3(2):139-44. PubMed ID: 20477103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.